https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-01-04 / Int J Hyperthermia 2011;27(1):63-73
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-01-04 / Int J Hyperthermia 2011;27(1):63-732011-01-04 00:00:002019-02-15 10:00:33KNK437, a benzylidene lactam compound, sensitises prostate cancer cells to the apoptotic effect of hyperthermia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-01-01 / Therapy 2011 Jan;8(1):43-54
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-01-01 / Therapy 2011 Jan;8(1):43-542011-01-01 00:00:002019-02-15 08:35:15Immunotherapy as a strategy for the treatment of non-small-cell lung cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-01-01 / Zhonghua Fu Chan Ke Za Zhi 2011 Jan;46(1):52-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-01-01 / Zhonghua Fu Chan Ke Za Zhi 2011 Jan;46(1):52-72011-01-01 00:00:002019-02-15 08:45:50[Study on the specific immunity induced by dendritic cell vaccine loading allogenic microvascular endothelial cell bEnd.3 antigen against U14 cervical cancer cell in mice]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-01-01 / Curr. Pharm. Des. 2011;17(23):2439-67
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-01-01 / Curr. Pharm. Des. 2011;17(23):2439-672011-01-01 00:00:002019-02-15 08:46:39New perspectives in glioma immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-01-01 / Int J Hyperthermia 2011;27(3):275-85
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-01-01 / Int J Hyperthermia 2011;27(3):275-852011-01-01 00:00:002019-02-15 09:17:21Inhibition of B16 murine melanoma metastasis and enhancement of immunity by fever-range whole body hyperthermia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-01-01 / Drugs 2011 Jan;71(1):101-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-01-01 / Drugs 2011 Jan;71(1):101-82011-01-01 00:00:002019-02-15 08:52:53Sipuleucel-T: in metastatic castration-resistant prostate cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-01-01 / J. Immunother. 2011 Jan;34(1):100-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-01-01 / J. Immunother. 2011 Jan;34(1):100-62011-01-01 00:00:002019-02-15 08:50:46Induction of cellular immune responses in patients with stage-I multiple myeloma after vaccination with autologous idiotype-pulsed dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-12-20 / Clin. Dev. Immunol. 2010;2010:565643
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-12-20 / Clin. Dev. Immunol. 2010;2010:5656432010-12-20 00:00:002019-02-15 08:40:10Gene carriers and transfection systems used in the recombination of dendritic cells for effective cancer immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-12-18 / Vaccine 2011 Feb;29(6):1185-93
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-12-18 / Vaccine 2011 Feb;29(6):1185-932010-12-18 00:00:002021-11-15 16:59:23Antitumor vaccination by Newcastle Disease Virus Hemagglutinin-Neuraminidase plasmid DNA application: changes in tumor microenvironment and activation of innate anti-tumor immunity
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-12-13 / J. Clin. Oncol. 2011 Jan;29(3):330-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-12-13 / J. Clin. Oncol. 2011 Jan;29(3):330-62010-12-13 00:00:002019-02-15 08:46:44Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in patients with recurrent malignant glioma
